Abstract
Opioid prescribing remains common despite known overdose-related harms. Less is known about links to nonoverdose morbidity. We determined the association between prescribed opioid receipt with incident cardiovascular disease (CVD) using data from the Veterans Aging Cohort Study, a national prospective cohort of Veterans with/without Human Immunodeficiency Virus (HIV) receiving Veterans Health Administration care. Selected participants had no/minimal prior exposure to prescription opioids, no opioid use disorder, and no severe illness 1 year after the study start date (baseline period). We ascertained prescription opioid exposure over 3 years after the baseline period using outpatient pharmacy fill/refill data. Incident CVD ascertainment began at the end of the prescribed opioid exposure ascertainment period until the first incident CVD event, death, or September 30, 2015. We used adjusted Cox proportional hazards regression models with matching weights using propensity scores for opioid receipt to estimate CVD risk. Among 49,077 patients, 30% received opioids; the median age was 49 years, 97% were male, 49% were Black, and 47% were currently smoking. Prevalence of hypertension, diabetes, current smoking, alcohol and cocaine use disorder, and depression was higher in patients receiving opioids versus those not but were well-balanced by matching weights. Unadjusted CVD incidence rates per 1,000-person-years were higher among those receiving opioids versus those not: 17.4 (95% confidence interval [CI], 16.5–18.3) versus 14.7 (95% CI, 14.2–15.3). In adjusted analyses, those receiving opioids versus those not had an increased hazard of incident CVD (adjusted hazard ratio 1.16 [95% CI, 1.08–1.24]). Prescribed opioids were associated with increased CVD incidence, making opioids a potential modifiable CVD risk factor. Perspective: In a propensity score weighted analysis of Veterans Administration data, prescribed opioids compared to no opioids were associated with an increased hazard of incident CVD. Higher opioid doses compared with lower doses were associated with increased hazard of incident CVD. Opioids are a potentially modifiable CVD risk factor.
Original language | English |
---|---|
Article number | 104436 |
Journal | Journal of Pain |
Volume | 25 |
Issue number | 5 |
DOIs | |
State | Published - May 2024 |
Bibliographical note
Publisher Copyright:© 2024
Funding
This work was funded by support from the National Institute on Drug Abuse ( 5R01DA040471 , 1R01DA047347 ) and the National Institute on Alcohol Abuse and Alcoholism ( 5U01AA020790 ). M.L. Sung was supported by the Department of Veterans Affairs (VA), Veterans Health Administration, VISN 1 Career Development Award. No conflicts of interest to report.
Funders | Funder number |
---|---|
National Institute on Drug Abuse | 1R01DA047347, 5R01DA040471 |
National Institute on Drug Abuse | |
National Institute on Alcohol Abuse and Alcoholism | 5U01AA020790 |
National Institute on Alcohol Abuse and Alcoholism | |
U.S. Department of Veterans Affairs | |
Office of Health Services Research and Development |
Keywords
- Opioids
- cardiovascular disease
- pain
- propensity score
- prospective cohort
ASJC Scopus subject areas
- Neurology
- Clinical Neurology
- Anesthesiology and Pain Medicine